What are the contraindications for Imitrex (sumatriptan)?

Contraindications for Imitrex (Sumatriptan)

Do not prescribe Imitrex to patients with any cardiovascular disease, uncontrolled hypertension, hemiplegic or basilar migraine, severe hepatic impairment, or those taking MAO-A inhibitors within 2 weeks, ergotamine-containing medications within 24 hours, or other triptans within 24 hours. 1

Absolute Contraindications

Cardiovascular and Cerebrovascular Disease

• Ischemic cardiac syndromes including:

  • Angina pectoris of any type (stable angina, Prinzmetal/vasospastic angina)
  • Any form of myocardial infarction (past or present)
  • Silent myocardial ischemia
  • Any other significant underlying cardiovascular disease 1

• Cerebrovascular syndromes including:

  • Strokes of any type
  • Transient ischemic attacks (TIAs) 1

• Peripheral vascular disease including:

  • Ischemic bowel disease 1

Hypertension

• Uncontrolled hypertension - Imitrex may increase blood pressure 1

Specific Migraine Types

• Hemiplegic migraine 1, 2
• Basilar migraine 1, 2

Drug Interactions (Temporal Contraindications)

• MAO-A inhibitors: Contraindicated during use or within 2 weeks of discontinuation (MAO-A inhibitors reduce sumatriptan clearance, significantly increasing systemic exposure) 1
• Ergotamine-containing or ergot-type medications (dihydroergotamine, methysergide): Must not be used within 24 hours of each other due to additive vasospastic effects 1, 2
• Other 5-HT1 agonists (triptans): Must not be used within 24 hours of another triptan 2

Hepatic Impairment

• Severe hepatic impairment 1, 2

Hypersensitivity

• Known hypersensitivity to sumatriptan or any component 1

Inappropriate Use

• As prophylactic therapy - Imitrex is for acute treatment only, not prevention 2

Important Clinical Context

Class-wide triptan contraindications apply to all triptans, not just Imitrex. These include ischemic vascular conditions, vasospastic coronary disease, uncontrolled hypertension, and other significant cardiovascular disease 2.

Common Pitfalls to Avoid

1. Pregnancy status: While not an absolute contraindication, Imitrex is Pregnancy Category C. Use only if potential benefit justifies potential risk to the fetus, as animal studies showed embryolethality and fetal abnormalities 1

2. Serotonin syndrome risk: While concurrent SSRI or SNRI use is not a contraindication despite earlier concerns, monitor for serotonin syndrome symptoms. Clinical evidence from 148 patients using SSRIs with sumatriptan showed most tolerate the combination without incident 3. However, remain vigilant for symptoms.

3. Impaired hepatic function: Contraindicated only in severe hepatic impairment; use caution with mild-to-moderate impairment 2, 1

4. Cardiac screening: Before prescribing to patients with cardiovascular risk factors (but no established disease), consider cardiovascular evaluation, as chest symptoms occur in 3-5% of patients 2